tiprankstipranks
Trending News
More News >
D.N.A Biomedical Solutions Ltd (IL:DNA)
:DNA
Israel Market
Advertisement

Dna Group (DNA) Ratios

Compare
0 Followers

Dna Group Ratios

IL:DNA's free cash flow for Q2 2024 was 1.00. For the 2024 fiscal year, IL:DNA's free cash flow was decreased by and operating cash flow was -5.15. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
60.77 97.73 83.56 83.32 <0.01
Quick Ratio
60.77 97.73 83.56 83.32 <0.01
Cash Ratio
60.67 97.37 83.31 82.54 <0.01
Solvency Ratio
6.50 0.04 -9.48 72.27 -1.68
Operating Cash Flow Ratio
0.32 -0.99 -0.45 -8.12 -0.06
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 -2.16
Net Current Asset Value
65.61M 65.47M 64.05M 23.63M -10.46M
Leverage Ratios
Debt-to-Assets Ratio
0.00 0.00 0.00 0.00 0.02
Debt-to-Equity Ratio
0.00 0.00 0.00 0.00 0.04
Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.03
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.03 1.02 1.02 1.01 2.33
Debt Service Coverage Ratio
0.00 0.00 0.00 -172.03 4.77
Interest Coverage Ratio
0.00 0.00 0.00 221.95 -5.85K
Debt to Market Cap
0.00 0.00 0.00 0.00 0.01
Interest Debt Per Share
0.00 0.00 0.00 <0.01 <0.01
Net Debt to EBITDA
0.00 30.68 0.00 0.00 0.00
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%0.00%0.00%
EBIT Margin
-603.49%-710.46%-1017.68%0.00%0.00%
EBITDA Margin
0.00%-710.46%0.00%0.00%0.00%
Operating Profit Margin
6572.55%-1114.38%-4344.29%0.00%0.00%
Pretax Profit Margin
7455.12%-384.64%-4202.86%0.00%0.00%
Net Profit Margin
7369.72%-384.64%-4202.86%0.00%0.00%
Continuous Operations Profit Margin
7369.72%-384.64%-4202.86%0.00%0.00%
Net Income Per EBT
98.85%100.00%100.00%100.00%100.00%
EBT Per EBIT
113.43%34.52%96.74%192.52%109.85%
Return on Assets (ROA)
16.22%-1.46%-28.71%33.64%-104.17%
Return on Equity (ROE)
17.93%-1.49%-29.38%33.82%-242.30%
Return on Capital Employed (ROCE)
14.62%-4.26%-29.96%17.57%-220.58%
Return on Invested Capital (ROIC)
15.54%-4.26%-78.68%10.49%-197.91%
Return on Tangible Assets
16.22%-1.46%-28.71%33.64%-104.17%
Earnings Yield
12.68%-1.47%-27.58%13.45%-85.13%
Efficiency Ratios
Receivables Turnover
0.00 0.00 0.00 0.00 0.00
Payables Turnover
0.00 0.00 0.00 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00
Asset Turnover
<0.01 <0.01 <0.01 0.00 0.00
Working Capital Turnover Ratio
<0.01 <0.01 0.01 0.00 0.00
Cash Conversion Cycle
0.00 0.00 0.00 0.00 0.00
Days of Sales Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
0.00 0.00 0.00 0.00 0.00
Operating Cycle
0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
<0.01 >-0.01 >-0.01 -0.03 -0.02
Free Cash Flow Per Share
<0.01 >-0.01 >-0.01 -0.03 -0.02
CapEx Per Share
0.00 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
0.00 0.00 0.00 0.00 -2.16
Operating Cash Flow to Sales Ratio
1.56 -2.22 -0.63 0.00 0.00
Free Cash Flow Yield
0.27%-0.85%-0.41%-1.71%-2.70%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
7.89 -67.80 -3.63 7.43 -1.17
Price-to-Sales (P/S) Ratio
579.60 260.79 152.38 0.00 0.00
Price-to-Book (P/B) Ratio
1.31 1.01 1.07 2.51 2.85
Price-to-Free Cash Flow (P/FCF) Ratio
371.56 -117.70 -241.05 -58.60 -37.04
Price-to-Operating Cash Flow Ratio
372.65 -117.70 -241.05 -58.60 -37.04
Price-to-Earnings Growth (PEG) Ratio
0.07 0.71 0.02 -0.06 0.02
Price-to-Fair Value
1.31 1.01 1.07 2.51 2.85
Enterprise Value Multiple
0.00 -6.03 0.00 0.00 0.00
Enterprise Value
64.71M 13.10M 19.60M 112.91M 22.87M
EV to EBITDA
0.00 -6.03 0.00 0.00 0.00
EV to Sales
281.94 42.82 35.01 0.00 0.00
EV to Free Cash Flow
180.74 -19.33 -55.38 -48.44 -37.43
EV to Operating Cash Flow
180.74 -19.33 -55.38 -48.44 -37.43
Tangible Book Value Per Share
0.82 0.67 0.69 0.63 0.26
Shareholders’ Equity Per Share
0.82 0.67 0.69 0.63 0.26
Tax and Other Ratios
Effective Tax Rate
-0.06 0.00 -1.63 0.40 0.07
Revenue Per Share
<0.01 <0.01 <0.01 0.00 0.00
Net Income Per Share
0.14 -0.01 -0.20 0.21 -0.63
Tax Burden
0.99 1.00 1.00 1.00 1.00
Interest Burden
-12.35 0.54 4.13 -7.76 12.10
Research & Development to Revenue
0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
5.25 3.57 2.19 0.00 0.00
Stock-Based Compensation to Revenue
1.04 0.22 1.74 0.00 0.00
Income Quality
0.02 0.58 0.02 -0.13 0.03
Currency in ILS
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis